文献速递产科母胎医学

早产临产和未足月胎膜早破中羊膜腔内感染和/或炎症与胎儿心脏向心性肥厚及舒张功能障碍相关

Intra-amniotic infection and/or inflammation is associated with fetal cardiac concentric hypertrophy and diastolic dysfunction in preterm labor and preterm prelabor rupture of membranes.
PubMed 文献 · Am J Obstet Gynecol · 2024-01-09

前瞻性队列研究对143例胎儿行胎儿超声心动图和羊膜腔穿刺,发现早产临产或未足月胎膜早破胎儿存在亚临床心脏向心性肥厚和舒张功能障碍,且羊膜腔内感染和/或炎症组改变更明显,提示早产后心血管效应至少部分源于产前。

要点

  • 早产临产或未足月胎膜早破胎儿已出现亚临床心脏向心性肥厚和舒张功能障碍。
  • 羊膜腔内感染和/或炎症组胎儿心脏结构及功能改变较无感染/炎症组更明显。
  • 羊水中肌钙蛋白I和N末端脑钠肽前体浓度在早产临产或未足月胎膜早破胎儿中升高。

核心结论

  • 早产临产或未足月胎膜早破胎儿显示心脏重构和亚临床功能障碍迹象,暴露于羊膜腔内感染和/或炎症者更明显,支持早产后儿童和成人的心血管效应至少部分源于产前。

研究设计与样本

  • 前瞻性队列研究,纳入2018年至2021年单胎妊娠24.0至34.0周因早产临产和/或未足月胎膜早破入院孕妇,羊膜腔内感染和/或炎症组n=41,无羊膜腔内感染和/或炎症组n=54,对照组为无早产临产或未足月胎膜早破的门诊孕妇n=48,共143例胎儿;入院时行胎儿超声心动图和羊膜腔穿刺。

主要发现

  • 左室壁厚度中位数羊膜腔内感染和/或炎症组0.93(四分位距0.72-1.16),无感染/炎症组0.79(0.66-0.92),对照组0.69(0.56-0.83),P<.001。
  • 三尖瓣A波持续时间羊膜腔内感染和/或炎症组0.23秒(0.21-0.25),无感染/炎症组0.24秒(0.22-0.25),对照组0.21秒(0.2-0.23),P=.007。
  • 羊水肌钙蛋白I浓度羊膜腔内感染和/或炎症组1413 pg/mL(927-2334),无感染/炎症组1190 pg/mL(829-1636),对照组841 pg/mL(671-959),P<.001。
  • 羊水N末端脑钠肽前体升高比例羊膜腔内感染和/或炎症组35.0%,无感染/炎症组17%,对照组0%,P=.005;最高N末端脑钠肽前体浓度见于羊膜腔内感染和/或炎症组。
  • 收缩功能各组间相似。

关键数值与推荐

  • 羊膜腔内感染定义为羊水培养阳性或16S核糖体RNA基因阳性。
  • 羊膜腔内炎症定义为羊水白细胞介素-6高于本课题组先前报道的截断值:未足月胎膜早破>1.43 ng/mL,早产临产>13.4 ng/mL。
  • 羊水生物标志物比较时数据校正了估计胎儿体重低于第10百分位、入院时未足月胎膜早破以及羊膜腔穿刺时孕周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preterm delivery is associated with cardiovascular remodeling and dysfunction in children and adults. However, it is unknown whether these effects are caused by the neonatal consequences of preterm birth or if these are already present in utero. OBJECTIVE: We evaluated fetal cardiac morphology and function in fetuses of mothers admitted for preterm labor or preterm prelabor rupture of membranes and the association of these changes with the presence of intra-amniotic infection and/or inflammation. STUDY DESIGN: In this prospective cohort study, fetal echocardiography and amniocentesis were performed at admission in singleton pregnant women with preterm labor and/or preterm prelabor rupture of membranes between 24.0 and 34.0 weeks' gestation with (intra-amniotic infection and/or inflammation group, n=41) and without intra-amniotic infection and/or inflammation (non-intra-amniotic infection and/or inflammation, n=54). Controls (n=48) were outpatient pregnant women without preterm labor or preterm prelabor rupture of membranes. Intra-amniotic infection was defined by a positive amniotic fluid culture or positive 16S ribosomal RNA gene. Intra-amniotic inflammation was defined by using the amniotic fluid interleukin-6 cutoff levels previously reported by our group being >1.43 ng/mL in preterm prelabor rupture of membranes and >13.4 ng/mL in preterm labor. Fetal cardiac morphology and function was evaluated using echocardiography, and troponin-I and N-terminal pro-brain natriuretic peptide concentrations were measured in amniotic fluid from women with preterm labor or preterm prelabor rupture of membranes and compared with 20 amniotic fluid Biobank samples obtained for reasons other than preterm labor or preterm prelabor rupture of membranes or cardiac pathology. The data were adjusted for the estimated fetal weight below the 10th percentile and for preterm prelabor rupture of membranes at admission and also for gestational age at amniocentesis when amniotic fluid biomarkers were compared. RESULTS: From 2018 to 2021, 143 fetuses were included; 95 fetuses were from mothers admitted with a diagnosis of preterm labor or preterm prelabor rupture of membranes, and among those, 41 (28.7%) were in the intra-amniotic infection and/or inflammation group and 54 (37.8%) were in the non-intra-amniotic infection and/or inflammation group. A total of 48 (33.6%) fetuses were included in the control group. Fetuses with preterm labor and/or preterm prelabor rupture of membranes had signs of subclinical cardiac concentric hypertrophy (median left wall thickness of 0.93 [interquartile range, 0.72-1.16] in the intra-amniotic infection and/or inflammation group; 0.79 [0.66-0.92] in the non-intra-amniotic infection and/or inflammation group; and 0.69 [0.56-0.83] in controls; P<.001) and diastolic dysfunction (tricuspid A duration 0.23 seconds [0.21-0.25], 0.24 [0.22-0.25], and 0.21 [0.2-0.23]; P=.007). Systolic function was similar among groups. Higher values of amniotic fluid troponin I (1413 pg/mL [927-2334], 1190 [829-1636], and 841 [671-959]; P<.001) and N-terminal pro-brain natriuretic peptide were detected (35.0%, 17%, and 0%; P=.005) in fetuses with preterm labor or preterm prelabor rupture of membranes when compared with the control group. The highest N-terminal pro-brain natriuretic peptide concentrations were found in the intra-amniotic infection and/or inflammation group. CONCLUSION: Fetuses with preterm labor or preterm prelabor rupture of membranes showed signs of cardiac remodeling and subclinical dysfunction, which were more pronounced in those exposed to intra-amniotic infection and/or inflammation. These findings support that the cardiovascular effects observed in children and adults born preterm have, at least in part, a prenatal origin.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Murillo C, Rueda C, Larroya M, et al. Intra-amniotic infection and/or inflammation is associated with fetal cardiac concentric hypertrophy and diastolic dysfunction in preterm labor and preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2024. PMID: 38290925. doi:10.1016/j.ajog.2023.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。